en · de · es · fr · pt
epitalon-notes.peptides6823.com › Data › Epitalon Background And Identification — Background and Details

Epitalon Background And Identification — Background and Details

By Editorial Desk · published 2026-07-22 · last reviewed 2026-08-01 · Data

The short version of Pineal peptide fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.

Epitalon Background And Identification

Literature searches for this compound must account for several spelling variants. Indexing databases contain epitalon, epithalon, epithalone, and AEDG, and relevant records are scattered across Russian-language and English-language journals that do not consistently cross-cite. Early publications describe the parent extract as a mixture of many peptides, whereas later work addresses the single synthetic tetrapeptide. That shift in nomenclature complicates comparison between studies, because extract data and tetrapeptide data are sometimes cited interchangeably. A search strategy omitting the alternate spellings will return an incomplete set of references.

Reported biological findings come mainly from cell culture and rodent experiments. Those studies describe changes in telomerase catalytic subunit expression, melatonin rhythm amplitude, and antioxidant enzyme activity after peptide exposure. Human data are sparse and consist of small trials with limited blinding and inconsistent endpoints. The proposed mechanisms remain hypotheses rather than established facts, and there is no consensus on whether effects observed in animals carry over to people. Independent replication outside the original research groups is limited, which is a recognised gap in the published literature.

The parent extract epithalamin was characterised as a low-molecular-weight fraction of pineal tissue rather than a single defined chemical entity. Researchers fractionated it and tested successive fragments for activity, a screening approach typical of peptide discovery work in that era. Epitalon emerged from that process as one of the shorter sequences of interest. Because the original extract was never fully resolved into individual components, claims about which constituent drives a given effect rest on inference. This distinction matters when reading older reports that attribute extract observations to the tetrapeptide itself.

Research Claims and Evidence Status

Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.

No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.

The most frequently cited laboratory finding is that AEDG increased telomerase activity and extended telomere length in cultured human somatic cells. That work used fetal fibroblast strains and reported changes in enzyme activity alongside altered division counts. Replication by unrelated groups has been limited, and the published record is largely a single-laboratory series rather than a multi-centre programme. The result supports a hypothesis about peptide influence on gene expression in cell culture; it does not by itself establish an effect on telomere length in living animals or in people.

Epitalon at a glance

PropertyValueNotes
Chemical classSynthetic tetrapeptideFour amino acid residues
Residue sequenceAla-Glu-Asp-GlyAbbreviated AEDG
Approximate mass390.35 DaMonoisotopic, free base form
Parent preparationEpithalamin extractDerived from pineal tissue
Common spelling variantsEpithalon, epithalone, AEDGAffects literature retrieval

Chemical Identity and Research Background

In its supplied form epitalon is a white to off-white powder, usually lyophilized and often hygroscopic. It dissolves readily in water and in aqueous buffers, and it is commonly handled as the acetate or trifluoroacetate salt to improve stability during purification and drying. The amide backbone is labile in aqueous media, so solutions are less durable than the dry solid. Handling notes in the chemical literature therefore emphasize keeping the powder dry, cool and shielded from light until it is dissolved.

Epitalon is a synthetic tetrapeptide whose sequence is alanine-glutamate-aspartate-glycine, written in single-letter code as AEDG. The four residues are joined by three peptide bonds, giving a linear backbone with no branching and no disulfide bridges. Its calculated molecular mass for the free form is approximately 390.3 daltons, a figure that rises when the compound is supplied as an acetate or trifluoroacetate salt. Because the chain is short, the molecule is defined entirely by its residue order rather than by any folded three-dimensional structure.

The compound is described in the literature as a derivative of epithalamin, a preparation obtained from bovine pineal tissue. Work on this peptide family was carried out mainly by a research group in Saint Petersburg beginning in the 1980s, and the substance was later registered for clinical use in Russia under the name Epitalon. Outside that region it is generally treated as a research chemical rather than an approved medicine. Statements about its biological activity rest on a relatively small number of studies, and independent replication remains limited.

Related pages on this site

Stability Handling and Quality Control

Typical storage for the lyophilized powder is −20 °C or lower, in a sealed container protected from light and moisture. Hygroscopic material should be allowed to equilibrate to room temperature before the vial is opened, which limits condensation on the contents. Working solutions are commonly divided into single-use aliquots and frozen to avoid repeated freeze-thaw cycles. Dilute solutions are more prone to adsorption onto plastic surfaces and to loss during filtration, so procedures that minimize transfers and use low-binding labware are preferable.

Reversed-phase high-performance liquid chromatography is the standard approach for assessing purity, usually with ultraviolet detection near 214 nm, where the peptide bond absorbs. Mass spectrometry, most often with electrospray ionization, confirms the molecular mass and helps reveal truncation or deletion byproducts. Amino acid analysis can verify composition, and counterion content is sometimes measured because peptides purified with trifluoroacetic acid retain variable amounts of that salt. Purity figures reported without a stated method and detection wavelength are difficult to interpret.

Background from the literature

"The single most important synthetic application of alkyl hydroperoxides is without doubt the metal-catalysed epoxidation of alkenes." In the Halcon process tert-butyl hydroperoxide (TBHP) is employed for the production of propylene oxide. Of specialized interest, chiral epoxides are prepared using hydroperoxides as reagents in the Sharpless epoxidation. Hydroperoxides are intermediates in the production of many organic compounds in industry. For example, the cobalt catalyzed oxidation of cyclohexane to cyclohexanone: C6H12 + O2 → (CH2)5C=O + H2O Drying oils, as found in many paints and varnishes, function via the formation of hydroperoxides.

CooA is a homodimeric, heme-containing transcription factor of the CAP/CRP family, with each monomer comprising an N-terminal heme-binding regulatory domain and a C-terminal helix-turn-helix motif that acts as a DNA-binding domain. The N-terminal domain coordinates a b-type heme whose axial ligands differ between species (for example, His-Pro versus His-His), and carbon monoxide (CO) binding to this heme triggers conformational changes that activate DNA binding. The two subunits associate through a coiled-coil-like interface, positioning the paired helix–turn–helix motifs to recognize target palindromic sequences in promoter DNA and thereby regulate genes involved in CO oxidation. Several structures of CooA have been solved, including: RrCooA in the ferrous state (1FT9), ChCooA in the ferrous, imidazole-bound state (2FMY), ChCooA in the ferrous, CO-bound state (2HKX).

Many readers have puzzled over the ending of Ubik, when Glen Runciter finds a Joe Chip coin in his pocket. What does it mean? Is Runciter dead? Are Joe Chip and the others alive? Actually, this is meant to tell you that we can't be sure of anything in the world that we call 'reality.' It is possible that they are all dead and in cold pac or that the half-life world can affect the full-life world. It is also possible that they are all alive and dreaming. Peter Fitting sees parallels between the God-Devil/Life-Death relationship of Ubik and the antagonist's consumptive abilities within half-life, and the commercialized industry between psychics and psychic-inhibiting "inertials" which occupies the novel's "reality". Fitting also notes Dick's effort to desacralize and commercialize Ubik through the ironic advertising messages which begin each chapter.

28 December – A new model of the largest neutron stars finds an 80–90% chance that they contain quark-matter cores. 29 December – A metascience study estimates the total amount of article processing charges paid to publish with open access in journals controlled by the five large commercial publishers from 2015–2018 to be $1.06 billion. On 12 December, it is reported that the number of paper retractions has hit a new record of over 10,000 in 2023, with around 80% coming from journals owned by Hindawi, mostly special issues overseen by guest editors. Promising innovations relating to global challenges are reported: a flying firehose robot, the Dragon Firefighter (22 Dec), completion of the first functional 105 meters tall more-modular Modvion wooden wind turbine is reported (28 Dec). Promising results of health and medical research are reported: news reports about a portable EEG helmet with significant accuracy of decoding thought words to text, DeWave (12 Dec), carrots against cancer-risk (17 Dec).

Sources: en.wikipedia.org

Further detail

=== Bone repair === Bone has a unique and well-documented natural healing process that normally is sufficient to repair fractures and other common injuries. Misaligned breaks due to severe trauma, as well as treatments like tumor resections of bone cancer, are prone to improper healing if left to the natural process alone. Scaffolds composed of natural and artificial components are seeded with mesenchymal stem cells and placed in the defect. Within four weeks of placing the scaffold, newly formed bone begins to integrate with the old bone and within 32 weeks, full union is achieved. Further studies are necessary to fully characterize the use of cell-based therapeutics for treatment of bone fractures. Stem cells have been used to treat degenerative bone diseases in dogs. The normally recommended treatment for dogs that have Legg–Calve–Perthes disease is to remove the head of the femur after the degeneration has progressed. Recently, mesenchymal stem cells have been injected directly in to the head of the femur, with success not only in bone regeneration, but also in pain reduction.

=== Books === Hocking, A. D.; Pitt, J. I.; Samson, Robert A.; Thrane, U., eds. (2006). Advances in Food Mycology. Advances in Experimental Medicine and Biology. Vol. 571. doi:10.1007/0-387-28391-9. ISBN 978-0-387-28385-2. McLauchlin, Jim; Little, Christine; Hobbs, Betty C. (2007). Hobbs' Food Poisoning and Food Hygiene. CRC Press. doi:10.1201/b13378. ISBN 978-1-4441-1374-7. Glass, Kathleen; Marshall, Kristin (2013). "Clostridium botulinum". Foodborne Infections and Intoxications. pp. 371–387. doi:10.1016/B978-0-12-416041-5.00027-5. ISBN 978-0-12-416041-5. Smith JL (2005). Fratamico PM, Bhunia AK, Smith JL (eds.). Foodborne Pathogens: Microbiology And Molecular Biology. Horizon Scientific Press. ISBN 978-1-904455-00-4.

== Post summit == From 11 to 12 November 2025, the G7 Foreign Ministers' Meeting was held at Niagara-on-the-Lake, and joint statement was issued. The joint statement showed their consensus on Ukraine and Sudan, but stayed away from contentious issues like the US military strikes on boats in the Caribbean and trade. They are increasing the economic costs to Russia and exploring measures against those who finance Russia's war efforts. Also, they raised alarm over China's military buildup and reiterated their resolve to create an alternative to its dominance in critical mineral supplies, and reaffirmed the importance of a Free and Open Indo-Pacific based on the rule of law.

=== 2000: Glaxo Wellcome and SmithKline Beecham merger === Glaxo Wellcome and SmithKline Beecham announced their intention to merge in January 2000. The merger was completed on 27 December that year, forming GlaxoSmithKline (GSK). The company's global headquarters were at GSK House, Brentford, London, officially opened in 2002, by then-Prime Minister Tony Blair. The building was erected at a cost of £300 million and as of 2002 was home to 3,000 administrative staff.

=== Purpose === There are two major applications to studying the genome at the single-cell level. One application is to track the changes that occur in bacterial populations, where phenotypic differences are often seen. These differences are easily missed by bulk sequencing of a population, but can be observed in single-cell sequencing. The second major application is to study the genetic evolution of cancer. Since cancer cells are constantly mutating it is of great interest to researchers to see how cancers evolve at the level of individual cells. These patterns of somatic mutations and copy number aberration can be observed using single-cell sequencing.

Sources: en.wikipedia.org

Frequently asked questions

What is epitalon derived from?

It is based on epithalamin, a peptide-rich preparation obtained from pineal gland tissue and studied in the former Soviet Union. Researchers later identified the tetrapeptide AEDG as a constituent fragment of that material. Modern supplies are produced by chemical synthesis rather than tissue extraction.

Is epitalon identical to epithalamin?

No. Epithalamin is a heterogeneous extract containing many peptides, while epitalon is a single synthesised tetrapeptide. Publications sometimes treat findings from the two as equivalent, which is a common source of confusion. Their compositions differ and they are not interchangeable in analytical terms.

Why are human studies so limited?

Most published work uses cell cultures or rodents because those models are faster and less costly to run. The few human trials that have been reported are small, and several lack control groups or blinding. This restricts what can reasonably be concluded about effects in people.

Has epitalon been studied in people?

Small studies with human participants have been reported, chiefly in Russian-language journals, but they are limited in size and design. No large randomised controlled trial with published results is available.

Network